Purified recombinant Human IFN alpha D protein Expression System: E.coli Bioactivity: The EC50 for interferon in a cytopathic effect inhibition assay is ~1 U/mL (Human) and ~5 U/mL (Bovine)
Reinheit
> 95 % pure
Endotoxin-Niveau
< 1 EU/µg
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
10000000 U/mL
Buffer
Supplied as a liquid in PBS with 0.1 % BSA.
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-80 °C
Target
IFN-alpha D (IFNAD)
(Interferon-alpha-D (IFNAD))
Andere Bezeichnung
IFN alpha D
Synonyme
interferon-alpha-D Protein, IFNAD Protein
Hintergrund
Interferon alpha A and D are produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. Interferon-Alpha A/D Bg/II is an alpha interferon hybrid that crosses the species barrier. The Bg/II denotes the restriction enzyme site from which this hybrid is constructed from recombinant human interferons Alpha A and Alpha D. Interferon-Alpha A/D has been proven to be active on many mammalian cells. It can substitute for human, monkey, mouse, bovine, rat, cat, dog, rabbit, sheep, goat, horse, pig or hamster type I interferon (alpha, beta, omega and tau). Alternative Names: Interferon alpha D protein